Clinical trial
Trial of Buprenorphine/Naloxone for Opiate Dependence - 2
NCT00000353 · National Institute on Drug Abuse (NIDA), NIH · Completed
Key facts
| NCT number | NCT00000353 |
|---|---|
| Title | Trial of Buprenorphine/Naloxone for Opiate Dependence - 2 |
| Official title | Efficacy/Safety Trial of Buprenorphine/Nx for Opiate Dependence |
| Lead sponsor | National Institute on Drug Abuse (NIDA), NIH |
| Collaborators | University of Pennsylvania |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Opioid-Related Disorders, Substance-Related Disorders |
| Intervention type | Drug |
| Interventions | Buprenorphine/naloxone |
| Enrollment | 0 |
| Start date | Oct 1, 1996 |
| Primary completion | Sep 1, 1997 |
| Completion | Oct 1, 1997 |
| First posted | Sep 21, 1999 |
| Last update posted | Jan 18, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: